Quantitation of anti-Xa activity when monitoring is required for a patient receiving a low molecular weight heparin or heparinoid - 1 test
Quantitation of anti-Xa activity when monitoring is required for a patient receiving a low molecular weight heparin or heparinoid - 1 test
| Release | Change | Old | New |
|---|---|---|---|
| July 2026 | Fee ↑ | $38.8 | $39.8 |
Data sourced from Australian Government publications · Not an official government service